NLT SPINE, a clinical stage VC-backed company, specializes in the development and marketing of innovative Minimally Invasive Spinal Surgery (MISS) products for treating degenerative spinal conditions. The company's vision is to improve patient care by shifting from traditional open surgical routines to MISS, employing new methods and technologies to enhance safety, predictability and outcomes.